ImageneBio Net Debt from 2010 to 2026
| IMA Stock | 6.94 0.09 1.31% |
Net Debt | First Reported 2019-12-31 | Previous Quarter -52.6 M | Current Value -92.2 M | Quarterly Volatility 88.9 M |
Check ImageneBio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ImageneBio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Selling General Administrative of 14.6 M or Total Revenue of 3.8 M, as well as many indicators such as Price To Sales Ratio of 118, Dividend Yield of 0.0 or PTB Ratio of 8.24. ImageneBio financial statements analysis is a perfect complement when working with ImageneBio Valuation or Volatility modules.
ImageneBio | Net Debt | Build AI portfolio with ImageneBio Stock |
Latest ImageneBio's Net Debt Growth Pattern
Below is the plot of the Net Debt of ImageneBio over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. ImageneBio's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ImageneBio's overall financial position and show how it may be relating to other accounts over time.
| Net Debt | 10 Years Trend |
|
Net Debt |
| Timeline |
ImageneBio Net Debt Regression Statistics
| Arithmetic Mean | (19,052,696) | |
| Geometric Mean | 54,491,358 | |
| Coefficient Of Variation | (441.08) | |
| Mean Deviation | 67,206,384 | |
| Median | 44,420,000 | |
| Standard Deviation | 84,037,884 | |
| Sample Variance | 7062.4T | |
| Range | 269.7M | |
| R-Value | (0.60) | |
| Mean Square Error | 4817T | |
| R-Squared | 0.36 | |
| Significance | 0.01 | |
| Slope | (9,993,049) | |
| Total Sum of Squares | 112997.9T |
ImageneBio Net Debt History
Other Fundumenentals of ImageneBio
ImageneBio Net Debt component correlations
Click cells to compare fundamentals
About ImageneBio Financial Statements
ImageneBio stakeholders use historical fundamental indicators, such as ImageneBio's Net Debt, to determine how well the company is positioned to perform in the future. Although ImageneBio investors may analyze each financial statement separately, they are all interrelated. For example, changes in ImageneBio's assets and liabilities are reflected in the revenues and expenses on ImageneBio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ImageneBio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Debt | -28.7 M | -30.1 M | |
| Net Debt To EBITDA | 0.59 | 0.56 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ImageneBio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ImageneBio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Imagenebio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Imagenebio Stock:Check out the analysis of ImageneBio Correlation against competitors. For information on how to trade ImageneBio Stock refer to our How to Trade ImageneBio Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImageneBio. If investors know ImageneBio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImageneBio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ImageneBio is measured differently than its book value, which is the value of ImageneBio that is recorded on the company's balance sheet. Investors also form their own opinion of ImageneBio's value that differs from its market value or its book value, called intrinsic value, which is ImageneBio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImageneBio's market value can be influenced by many factors that don't directly affect ImageneBio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImageneBio's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImageneBio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImageneBio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.